ClinicalTrials.Veeva

Menu

Doppler and Biological Second Trimester Placental Insufficiency Screening (ARTULEP)

R

Regional University Hospital Center (CHRU)

Status

Completed

Conditions

Pre-Eclampsia
Fetal Growth Retardation
Placental Insufficiency

Study type

Observational

Funder types

Other

Identifiers

NCT00465634
PHRR02-FP/ARTULEP

Details and patient eligibility

About

To assess the role of uterine artery and maternal serum leptin and lipids and their combination in screening for pre-eclampsia and small-for-gestational-age (SGA) fetuses at 20-24 weeks of gestation

Full description

Pre-eclampsia (PE) and intrauterine growth restriction (IUGR) are known as major factors in perinatal morbidity and mortality. Routine antenatal care is focused on the detection of women at increased risk to apply this population a program of careful monitoring and appropriate intervention.

Uterine artery Doppler during anomaly scan at 20 to 24 weeks in selected women at increased risk, has proved to be accurate to detect those who will develop PE or IUGR during the second half of pregnancy. Studies have reported detection rate of 50-70% for a 5% false positive rate in women developing early pre-eclampsia.

A variety of proteins and hormones have been studied as potential markers for pre-eclampsia. Among these protein serum placental leptin has demonstrated higher levels in pregnant women who will subsequently develop pre-eclampsia. However, screening performance of leptin detection in early pregnancy has never been assessed.

Our study is aimed to evaluate the performance of serum leptin measurement in association with uterine artery Doppler as a screening too for placental insufficiency.

Enrollment

235 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic hypertension under medication
  • Diabetes
  • Thrombophilia
  • Previous history of pre-eclampsia
  • Previous history of unexplained stillbirth
  • Previous history of placental abruption
  • Previous history of SGA (< 10th centile)
  • History of pre-eclampsia or chronic hypertension before 45 years in the mother or a sister
  • Obesity (BMI>30)
  • Nulliparous after 40 years
  • Assisted conception with donor

Exclusion criteria

  • Multiple pregnancy
  • Complicated pregnancy with a high probability of required fetal extraction before term
  • Pregnancy requiring termination
  • Unability to understand the study

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems